Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems

Olfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functi...

Full description

Bibliographic Details
Main Authors: Yae Rim Choi, Jaewon Shim, Jae-Ho Park, Young-Suk Kim, Min Jung Kim
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/21/10/3468
_version_ 1797533859362897920
author Yae Rim Choi
Jaewon Shim
Jae-Ho Park
Young-Suk Kim
Min Jung Kim
author_facet Yae Rim Choi
Jaewon Shim
Jae-Ho Park
Young-Suk Kim
Min Jung Kim
author_sort Yae Rim Choi
collection DOAJ
description Olfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functions are unknown. Herein, we present an experimental strategy using a surface plasmon resonance (SPR) system and a cell-based assay that allowed the identification of orphan OR6M1 as a new anticancer target in the MCF-7 breast cancer cell line. After the construction of stable OR6M1-expressing cells, the SPR-based screening of 108 chemicals for ligand activity was performed against OR6M1-expressing whole cells (primary screening) or membrane fragments (secondary screening). As a result, anthraquinone (AQ) and rutin were discovered to be new OR6M1 ligands. Based on calcium imaging in OR6M1-expressing Hana3A cells, AQ and rutin were classified as an OR6M1 agonist and antagonist, respectively. Cell viability and live/dead assays showed that AQ induced the death of MCF-7 cells, which was inhibited by rutin. Therefore, OR6M1 may be considered an anticancer target, and AQ may be considered a chemotherapeutic agent. This combined method can be widely used to discover the ligands and functions of other orphan GPCRs.
first_indexed 2024-03-10T11:21:38Z
format Article
id doaj.art-17bb00072cb1403bb7ca3154b49f90c3
institution Directory Open Access Journal
issn 1424-8220
language English
last_indexed 2024-03-10T11:21:38Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Sensors
spelling doaj.art-17bb00072cb1403bb7ca3154b49f90c32023-11-21T19:58:07ZengMDPI AGSensors1424-82202021-05-012110346810.3390/s21103468Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based SystemsYae Rim Choi0Jaewon Shim1Jae-Ho Park2Young-Suk Kim3Min Jung Kim4Research Group of Natural Materials and Metabolism, Korea Food Research Institute, Wanju 55365, KoreaResearch Group of Natural Materials and Metabolism, Korea Food Research Institute, Wanju 55365, KoreaResearch Group of Healthcare, Korea Food Research Institute, Wanju 55365, KoreaDepartment of Food Science and Engineering, Ewha Womans University, Seoul 03760, KoreaResearch Group of Natural Materials and Metabolism, Korea Food Research Institute, Wanju 55365, KoreaOlfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functions are unknown. Herein, we present an experimental strategy using a surface plasmon resonance (SPR) system and a cell-based assay that allowed the identification of orphan OR6M1 as a new anticancer target in the MCF-7 breast cancer cell line. After the construction of stable OR6M1-expressing cells, the SPR-based screening of 108 chemicals for ligand activity was performed against OR6M1-expressing whole cells (primary screening) or membrane fragments (secondary screening). As a result, anthraquinone (AQ) and rutin were discovered to be new OR6M1 ligands. Based on calcium imaging in OR6M1-expressing Hana3A cells, AQ and rutin were classified as an OR6M1 agonist and antagonist, respectively. Cell viability and live/dead assays showed that AQ induced the death of MCF-7 cells, which was inhibited by rutin. Therefore, OR6M1 may be considered an anticancer target, and AQ may be considered a chemotherapeutic agent. This combined method can be widely used to discover the ligands and functions of other orphan GPCRs.https://www.mdpi.com/1424-8220/21/10/3468olfactory receptorOR6M1surface plasmon resonanceanthraquinoneMCF-7 breast cancer cell linerutin
spellingShingle Yae Rim Choi
Jaewon Shim
Jae-Ho Park
Young-Suk Kim
Min Jung Kim
Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
Sensors
olfactory receptor
OR6M1
surface plasmon resonance
anthraquinone
MCF-7 breast cancer cell line
rutin
title Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
title_full Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
title_fullStr Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
title_full_unstemmed Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
title_short Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
title_sort discovery of orphan olfactory receptor 6m1 as a new anticancer target in mcf 7 cells by a combination of surface plasmon resonance based and cell based systems
topic olfactory receptor
OR6M1
surface plasmon resonance
anthraquinone
MCF-7 breast cancer cell line
rutin
url https://www.mdpi.com/1424-8220/21/10/3468
work_keys_str_mv AT yaerimchoi discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems
AT jaewonshim discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems
AT jaehopark discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems
AT youngsukkim discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems
AT minjungkim discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems